J Mallolas Selected Research

J Mallolas Research Topics

Disease

5	Acquired Immunodeficiency Syndrome (AIDS) 09/2012 - 01/2000
4	HIV Infections (HIV Infection) 05/2007 - 11/2001
3	Ischemia 06/2014 - 01/2006
3	Brain Ischemia (Cerebral Ischemia) 06/2014 - 01/2006
3	Infections 04/2014 - 03/2005
3	Lipodystrophy 05/2006 - 11/2000
2	Stroke (Strokes) 05/2014 - 01/2006
2	Coinfection 09/2012 - 07/2001
2	Chronic Hepatitis C 06/2009 - 03/2005
2	Hepatitis C 06/2009 - 07/2001
2	Opportunistic Infections (Opportunistic Infection) 03/2007 - 10/2001
2	Fragile X Syndrome (Martin Bell Syndrome) 08/2000 - 04/2000
1	Cytomegalovirus Infections (Inclusion Disease) 12/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2018
1	Vascular Diseases (Vascular Disease) 05/2018
1	Fibrosis (Cirrhosis) 12/2016
1	Infarction (Infarctions) 05/2014
1	Exanthema (Rash) 04/2008
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2007
1	Liver Diseases (Liver Disease) 05/2007
1	Communicable Diseases (Infectious Diseases) 05/2007
1	Tuberculosis (Tuberculoses) 03/2007
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2005
1	Disease Progression 04/2003
1	Progressive Multifocal Leukoencephalopathy 04/2003
1	Hypersensitivity (Allergy) 04/2003
1	Hepatitis 07/2001
1	Hepatitis B 07/2001
1	Abdominal Obesity 02/2001
1	Neoplasms (Cancer) 01/2001
1	Phenylketonurias (Phenylketonuria) 01/2001
1	Kaposi Sarcoma (Kaposi's Sarcoma) 12/2000
1	Cryptococcal Meningitis 11/2000
1	Insulin Resistance 11/2000
1	Hypercholesterolemia 11/2000
1	Hypertriglyceridemia 11/2000
1	Ulcerative Colitis 07/2000
1	Cysts 07/2000
1	Intellectual Disability (Idiocy) 04/2000
1	Iritis 01/2000
1	Cytomegalovirus Retinitis 01/2000

Drug/Important Bio-Agent (IBA)

4	Protease Inhibitors (Protease Inhibitor)IBA 05/2018 - 11/2000
4	NucleosidesIBA 09/2012 - 11/2000
3	Proteins (Proteins, Gene)FDA Link 06/2014 - 08/2000
3	Reverse Transcriptase InhibitorsIBA 11/2001 - 11/2000
2	Nevirapine (Viramune)FDA Link 04/2008 - 07/2001
2	EnzymesIBA 03/2005 - 04/2000
2	efavirenz (Sustiva)FDA Link 11/2001 - 11/2000
2	RNA (Ribonucleic Acid)IBA 07/2001 - 11/2000
2	Human immunodeficiency virus 1 p16 proteaseIBA 02/2001 - 11/2000
2	AntigensIBA 01/2001 - 07/2000
1	Angiogenic ProteinsIBA 06/2014
1	HMGA1a ProteinIBA 06/2014
1	Messenger RNA (mRNA)IBA 06/2014
1	Transcription Factors (Transcription Factor)IBA 06/2014
1	Protein Isoforms (Isoforms)IBA 05/2014
1	Leucine (L-Leucine)FDA Link 05/2014
1	CateninsIBA 05/2014
1	Hemoglobins (Hemoglobin)IBA 09/2012
1	LipidsIBA 09/2012
1	AlbuminsIBA 09/2012
1	Ribavirin (Virazole)FDA LinkGeneric 06/2009
1	InterferonsIBA 06/2009
1	Interferon-alpha (Interferon Alfa)IBA 06/2009
1	Pharmaceutical PreparationsIBA 03/2007
1	Rifampin (Rifampicin)FDA LinkGeneric 03/2007
1	Glutamic Acid (Glutamate)FDA Link 01/2006
1	Neuroprotective AgentsIBA 01/2006
1	Excitatory Amino Acid AntagonistsIBA 01/2006
1	Mitochondrial DNA (mtDNA)IBA 03/2005
1	abacavir, lamivudine, and zidovudine drug combination FDA Link 04/2003
1	Alanine Transaminase (SGPT)IBA 07/2001
1	Anti-Retroviral Agents (Antiretroviral Agents)IBA 02/2001
1	Indinavir (Crixivan)FDA Link 02/2001
1	Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA 01/2001
1	Insulin-Like PeptidesIBA 01/2001
1	Glucose (Dextrose)FDA LinkGeneric 11/2000
1	HDL CholesterolIBA 11/2000
1	Triglycerides (Triacylglycerol)IBA 11/2000
1	AntibodiesIBA 07/2000
1	TRPP Cation ChannelsIBA 07/2000
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 07/2000
1	DNA (Deoxyribonucleic Acid)IBA 07/2000
1	Immunoglobulin G (IgG)IBA 07/2000
1	5' Untranslated Regions (5' UTR)IBA 04/2000
1	Deoxyribonuclease EcoRI (Eco RI)IBA 04/2000
1	Cidofovir (Vistide)FDA Link 01/2000

Therapy/Procedure

9	Therapeutics 12/2019 - 01/2000
8	Highly Active Antiretroviral Therapy (HAART) 12/2019 - 01/2000
1	Artificial Respiration (Mechanical Ventilation) 12/2019
1	Catheters 04/2014
1	Lasers (Laser) 07/2000